Cocrystal Pharma (COCP) Interest Expenses (2010 - 2026)
Cocrystal Pharma (COCP) posted Interest Expenses of -$22000.0 for Q1 2026, up 87.91% sequentially from -$182000.0 in Q4 2025, and up 40.54% YoY from -$15653.8 in Q1 2025.
Cocrystal Pharma (COCP) Interest Expenses (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Interest Expenses for 17 years, with the latest figure at -$22000.0 in Q1 2026.
- Quarterly Interest Expenses rose 40.54% year-over-year to -$22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $506000.0 (up 63.23% YoY) and the FY2025 annual result came in at $674000.0, down 14.58% from the prior year.
- Interest Expenses improved to -$22000.0 in Q1 2026 per COCP's latest filing, from -$182000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $2.1 million in Q2 2024 and troughed at -$320000.0 in Q3 2023.
- A 5-year average of $225562.5 and a median of $41000.0 in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses slumped 1784.21% in 2023, then surged 1070.88% in 2024.
- Over 5 years, Interest Expenses stood at $19000.0 in 2022, then slumped by 1047.37% to -$180000.0 in 2023, then jumped by 515.0% to $747000.0 in 2024, then sank by 124.36% to -$182000.0 in 2025, then surged by 87.91% to -$22000.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered -$22000.0, -$182000.0, and $242000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.51 Mn |
| Jun 30, 2026 | 1.51 Mn |
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | -182,000.00 |
| Dec 31, 2025 | -182,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 268,000.00 |
| Jun 30, 2025 | 268,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Mar 31, 2025 | -37,000.00 |
| Dec 31, 2024 | 747,000.00 |
| Dec 31, 2024 | 747,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 2.13 Mn |
| Mar 31, 2024 | -220,000.00 |
| Mar 31, 2024 | -220,000.00 |